Clinical Trials Directory

Trials / Completed

CompletedNCT00794404

Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy

Evaluation of Power Doppler US Technique for the Diagnosis of Spondylarthropathy in Patients With Uncertain Diagnosis Consulting for Clinical Symptoms Suggestive of Spondylarthropathy

Status
Completed
Phase
Study type
Observational
Enrollment
489 (actual)
Sponsor
Dr Maria-Atonietta D'AGOSTINO · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the interest of enthesis sonography for the diagnosis of spondylarthritis, in patients with uncertain diagnosis consulting for clinical symptoms suggestive of spondylarthritis

Detailed description

Spondylarthritis (SPA) are the second most frequent inflammatory rheumatic disorders and, because it starts early in life and has a chronic progressive course, the impact of this disease on health resources and patient's life quality can be important. Because the characteritic signs of SPA, like radiological evidence of sacro-iliitis, appear late in time, the lag time between the onset first signs of SPA for the patient and the confirmed diagnosis can be very long (up to 8 years). Previous studies proved that patients who are affected by SPA are showing abnormal vascularization of peripheral enthesis more frequently than patients affected by other rheumatic diseases. Ultrasonography in B mode combined with power Doppler (PDUS) is a non invasive and highly sensitive toll which can detect enthesitis and abnormal vsacularization even for the patients who are not showing yet the evidence of SPA's symptomatology. Using PDUS as a early diagnosis tool could lead to the improvement of diagnostic procedures and therapeutic management of SpA and reduce the cost of diagnosis for patient and health insurances.

Conditions

Timeline

Start date
2004-12-01
Primary completion
2010-03-01
Completion
2010-12-01
First posted
2008-11-20
Last updated
2016-10-31

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00794404. Inclusion in this directory is not an endorsement.